[Federal Register Volume 65, Number 196 (Tuesday, October 10, 2000)]
[Notices]
[Page 60212]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-25896]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--International Pharmaceutical Aerosol Consortium 
for Toxicology Testing of HFA-134a (IPACT-I)

    Notice is hereby given that, on July 6, 2000, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), The International Pharmaceutical 
Aerosol Consortium for Toxicology Testing of HFA-134a (``IPACT-I'') 
filed written notifications simultaneously with the Attorney General 
and the Federal Trade Commission disclosing a change in name of some of 
its members.
    The notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances. Specifically, Astra AB, a member 
of IPACT-I, is now known as AstraZeneca AB, Sodertalje, Sweden; Rhone-
Poulenc Rorer Pharmaceuticals, Inc., a member of IPACT-I, is now known 
as Aventis Pharmaceuticals Products, Inc., Collegeville, PA; and Fisons 
plc, a member of IPACT-I, is now known as Fisons Ltd., Holmes Chapel, 
England, United Kingdom.
    No other changes have been made in either the membership or planned 
activity of IPACT-I. Membership in this joint research project remains 
open, and IPACT-I intends to file additional written notification 
disclosing all changes in membership.
    On August 7, 1990, IPACT-I filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to Section 6(b) of the Act on 
September 6, 1990 (55 Fed. Reg. 36710).
    The last notification was filed with the Department on December 3, 
1997. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on February 19, 1998 (63 FR 8477).

Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 00-25896 Filed 10-6-00; 8:45 am]
BILLING CODE 4410-11-M